Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lysosome-associated membrane proteins (LAMPs), particularly LAMP-1 and LAMP-2, are integral glycoproteins of the lysosomal membrane that play a crucial role in antigen processing and presentation. LAMP fusion strategies facilitate the targeting of antigens to endosomal/lysosomal compartments, thereby enhancing their processing for presentation on major histocompatibility complex (MHC) class II molecules to CD4+ T cells. This pathway is relevant for vaccine design, autoimmunity, and cancer immunotherapy by modulating immune recognition through enhanced antigen presentation.
Antigen targeting to lysosomes to enhance MHC class II presentation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lysosome-Associated Membrane Protein-Mediated Antigen Presentation Enhancement (LAMP-Mediated Antigen Presentation).